AKT1 and neoplasm: In this study we demonstrate that enhancing internalization of mIBG into tumor cells not only by HDACi but also by PI3K/AKT/mTOR inhibitors that represent a novel target and could therefore improve diagnostic precision in a larger number of patients improving efficacy of mIBG as a major therapeutic modality.